These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5212308)

  • 21. Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors.
    LaBrosse EH; Com-Nougué C; Zucker JM; Comoy E; Bohuon C; Lemerle J; Schweisguth O
    Cancer Res; 1980 Jun; 40(6):1995-2001. PubMed ID: 7371035
    [No Abstract]   [Full Text] [Related]  

  • 22. The carcinoembryonic antigen assay: Prognostic value in neural crest tumors.
    Frens DB; Bray PF; Wu JT; Lahey ME
    J Pediatr; 1976 Apr; 88(4 Pt 1):591-4. PubMed ID: 1255318
    [No Abstract]   [Full Text] [Related]  

  • 23. Urinary excretion of HMMA in children.
    Walters EG; Proctor DG; Elder GH; Walters G
    Ann Clin Biochem; 1989 Jan; 26 ( Pt 1)():44-8. PubMed ID: 2735747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion-weighted MRI for differentiation of neuroblastoma and ganglioneuroblastoma/ganglioneuroma.
    Gahr N; Darge K; Hahn G; Kreher BW; von Buiren M; Uhl M
    Eur J Radiol; 2011 Sep; 79(3):443-6. PubMed ID: 20462716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter: Catecholamine excretion levels in neuroblastoma.
    Bond JV
    Br Med J; 1974 Aug; 3(5930):574. PubMed ID: 4414138
    [No Abstract]   [Full Text] [Related]  

  • 26. [Relationship between urinary excretion of vanilmandelic acid (VMA) and clinical progress in 15 cases of neuroblastoma].
    Takada H; Inui A; Imashuku S; Kusunoki T; Sawada A
    Nihon Shonika Gakkai Zasshi; 1971 Oct; 75(10):917-23. PubMed ID: 5169739
    [No Abstract]   [Full Text] [Related]  

  • 27. [The importance of the determination of urinary catecholamines and urinary vanilmandelic acid in the diagnosis and control of neuroblastoma therapy].
    Rutiloni C; Serra GB
    Minerva Pediatr; 1968 Dec; 20(48):2481-7. PubMed ID: 5715834
    [No Abstract]   [Full Text] [Related]  

  • 28. Occurrence of secondary cystathioninuria in children with inherited metabolic disorders, liver diseases, neoplasms, cystic fibrosis and celiac disease.
    Endres W; Wuttge B
    Eur J Pediatr; 1978 Aug; 129(1):29-35. PubMed ID: 210019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benign pheochromocytoma associated with elevated excretion of homovanillic acid.
    Gitlow SE; Bertani LM; Greenwood SM; Wong BL; Dziedzic SW
    J Pediatr; 1972 Dec; 81(6):1112-6. PubMed ID: 4643029
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic Value of Diffusion-Weighted MRI for Tumor Characterization, Differentiation and Monitoring in Pediatric Patients with Neuroblastic Tumors.
    Neubauer H; Li M; Müller VR; Pabst T; Beer M
    Rofo; 2017 Jul; 189(7):640-650. PubMed ID: 28511265
    [No Abstract]   [Full Text] [Related]  

  • 31. Pyridoxal-5'-phosphate determination by a sensitive micromethod in human blood, urine and tissues; its relation to cystathioninuria in neuroblastoma and biliary atresia.
    Shin YS; Rasshofer R; Friedrich B; Endres W
    Clin Chim Acta; 1983 Jan; 127(1):77-85. PubMed ID: 6825312
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical significance of catecholamine excretion levels in diagnosis and treatment of neuroblastoma.
    Bond JV
    Arch Dis Child; 1975 Sep; 50(9):691-5. PubMed ID: 1190818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystathioninuria and homocystinuria.
    Levy HL; Mudd SH; Uhlendorf BW; Madigan PM
    Clin Chim Acta; 1975 Jan; 58(1):51-9. PubMed ID: 1122632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of neuroblastoma by qualitative and quantitative determination of catecholamine metabolites in urine.
    Gitlow SE; Bertani LM; Rausen A; Gribetz D; Dziedzic SW
    Cancer; 1970 Jun; 25(6):1377-83. PubMed ID: 5422912
    [No Abstract]   [Full Text] [Related]  

  • 35. Catecholamine measurements in pheochromocytoma and neuroblastoma.
    Spiegel HE
    Ann Clin Lab Sci; 1974; 4(3):174-7. PubMed ID: 4363482
    [No Abstract]   [Full Text] [Related]  

  • 36. Cases of neuroblastoma missed by the mass screening programs.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J; Kawai T
    Pediatr Res; 1989 Dec; 26(6):603-7. PubMed ID: 2602040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Four drug sequential chemotherapy for metastatic neuroblastoma.
    Helson L; Denoix L
    Eur J Cancer (1965); 1973; 9(11-12):883-5. PubMed ID: 4804316
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuroblastoma with intraspinal (dumbbell) extension.
    Holgersen LO; Santulli TV; Schullinger JN; Berdon WE
    J Pediatr Surg; 1983 Aug; 18(4):406-11. PubMed ID: 6620081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
    Horsmans Y; Desager JP; Harvengt C
    Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
    Cangemi G; Barco S; Reggiardo G; Viscardi E; Di Cataldo A; Garaventa A; Melioli G; Conte M
    Pediatr Blood Cancer; 2013 Dec; 60(12):E170-2. PubMed ID: 23813598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.